These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35681919)

  • 1. Grading Systems for Canine Urothelial Carcinoma of the Bladder: A Comparative Overview.
    Brambilla E; Govoni VM; Cavalca AMB; Laufer-Amorim R; Fonseca-Alves CE; Grieco V
    Animals (Basel); 2022 Jun; 12(11):. PubMed ID: 35681919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine urothelial carcinoma: expression of Periostin in spontaneous canine urothelial carcinoma and its correlation with histological features.
    Brambilla E; Ciaputa R; Crepaldi P; Dzimira S; Nowak M; Dziegiel P; Piotrowska A; Mollica Govoni V; Fonseca-Alves CE; Laufer-Amorim R; Stefanello D; Romussi S; Grieco V
    Front Vet Sci; 2023; 10():1258247. PubMed ID: 38076555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of Histological Grading Systems in Veterinary Medicine.
    Avallone G; Rasotto R; Chambers JK; Miller AD; Behling-Kelly E; Monti P; Berlato D; Valenti P; Roccabianca P
    Vet Pathol; 2021 Sep; 58(5):809-828. PubMed ID: 33769136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of Tat-interacting Protein 30 Expression Could be a Prognostic Marker in Bladder Urothelial Cancer.
    Li YP; Zhu JF; Huang KT; Wang RR; Cai B; Xie H; Chen HD
    Chin Med J (Engl); 2018 Jan; 131(2):188-193. PubMed ID: 29336367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: Clinicopathologic correlations and association with survival.
    Yang M; Yu Q; Liu J; Fu W; Cao Y; Yu L; Shao S; Wang X; Niu H; Wang Y
    J Surg Oncol; 2015 Sep; 112(4):430-5. PubMed ID: 26265374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α4 contributes to bladder urothelial carcinoma cell invasion and/or metastasis via regulation of E-cadherin and is a predictor of outcome in bladder urothelial carcinoma patients.
    Liu J; Cai M; Chen J; Liao Y; Mai S; Li Y; Huang X; Liu Y; Zhang J; Kung H; Zeng Y; Zhou F; Xie D
    Eur J Cancer; 2014 Mar; 50(4):840-51. PubMed ID: 24388773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated preoperative plasma fibrinogen level is an independent predictor of malignancy and advanced stage disease in patients with bladder urothelial tumors.
    Liu J; Li D; Cao L; Wang Z; Li Y; Liu H; Chen G
    Int J Surg; 2016 Dec; 36(Pt A):249-254. PubMed ID: 27826047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adenosine A2b receptor promotes tumor progression of bladder urothelial carcinoma by enhancing MAPK signaling pathway.
    Zhou Y; Chu X; Deng F; Tong L; Tong G; Yi Y; Liu J; Tang J; Tang Y; Xia Y; Dai Y
    Oncotarget; 2017 Jul; 8(30):48755-48768. PubMed ID: 28548944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma.
    Yang C; Zhou Y; Zhang L; Jin C; Li M; Ye L
    Int J Clin Exp Pathol; 2015; 8(2):1768-75. PubMed ID: 25973066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016".
    Compérat EM; Burger M; Gontero P; Mostafid AH; Palou J; Rouprêt M; van Rhijn BWG; Shariat SF; Sylvester RJ; Zigeuner R; Babjuk M
    Eur Urol Focus; 2019 May; 5(3):457-466. PubMed ID: 29366854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Differences Between Bladder and Upper Urinary Tract Carcinoma: Implications for Therapy.
    Sfakianos JP; Gul Z; Shariat SF; Matin SF; Daneshmand S; Plimack E; Lerner S; Roupret M; Pal S
    Eur Urol Oncol; 2021 Apr; 4(2):170-179. PubMed ID: 33386276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive urothelial carcinoma exhibiting basal cell immunohistochemical markers: A variant of urothelial carcinoma associated with aggressive features.
    Mai KT; Truong LD; Ball CG; Williams P; Flood TA; Belanger EC
    Pathol Res Pract; 2015 Aug; 211(8):610-8. PubMed ID: 26100813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-κB/MMP-7 signaling pathway.
    Liu JY; Dai YB; Li X; Cao K; Xie D; Tong ZT; Long Z; Xiao H; Chen MK; Ye YL; Liu B; Tan J; Tang J; Xu ZZ; Gan Y; Zhou YH; Deng F; He LY
    Cell Death Dis; 2017 Mar; 8(3):e2691. PubMed ID: 28333147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased NUSAP1 expression is associated with lymph node metastasis and survival prognosis in bladder urothelial carcinoma.
    Hou J; Lu Z; Liu X; Luo B; Qu G; Xu Y; Tang C
    Sci Rep; 2022 Apr; 12(1):7003. PubMed ID: 35487972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of Arp2 expression is associated with the prognosis and prediction of lymph node metastasis in bladder urothelial carcinoma.
    Xu N; Qu GY; Wu YP; Li XD; Lin MY; Chen SH; Xue XY; Wei Y
    Cancer Manag Res; 2018; 10():503-511. PubMed ID: 29593429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value and reproducibility of different microscopic characteristics in the WHO grading systems for pTa and pT1 urinary bladder urothelial carcinomas.
    Kvikstad V; Mangrud OM; Gudlaugsson E; Dalen I; Espeland H; Baak JPA; Janssen EAM
    Diagn Pathol; 2019 Aug; 14(1):90. PubMed ID: 31412916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Checkpoint Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 is Upregulated and Independently Predicts Unfavorable Prognosis in Bladder Urothelial Carcinoma.
    Lin G; Ye H; Wang J; Chen S; Chen X; Zhang C
    Nephron; 2019; 141(4):256-264. PubMed ID: 30602154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of grading of non-invasive urothelial carcinoma by digital pathology for routine diagnosis.
    Colling R; Colling H; Browning L; Verrill C
    BMC Cancer; 2021 Sep; 21(1):995. PubMed ID: 34488682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of transcription factor Twist1 in bladder urothelial carcinoma and its clinical significance.
    Tang X; Xing J; Li W; Wu Z; Zhang K; Zheng J
    J BUON; 2013; 18(1):211-9. PubMed ID: 23613408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of REDD1 Sensitizes Bladder Urothelial Carcinoma to Paclitaxel by Inhibiting Autophagy.
    Zeng Q; Liu J; Cao P; Li J; Liu X; Fan X; Liu L; Cheng Y; Xiong W; Li J; Bo H; Zhu Y; Yang F; Hu J; Zhou M; Zhou Y; Zou Q; Zhou J; Cao K
    Clin Cancer Res; 2018 Jan; 24(2):445-459. PubMed ID: 29084921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.